Reversine increases multipotent human mesenchymal cells differentiation potential. 2011

E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Among different human stem cell sources, adult mesenchymal stem cells from bone marrow (BMSCs), and more recently from adipose tissues (ASCs), have shown their capability to differentiate into a variety of different cell types, including osteoblasts, adipocytes, and muscle cells. However, mesenchymal stem cell differentiation toward certain cell types (including skeletal and cardiac muscle), while shown to be achievable, still suffers of low yields and needs to be greatly improved before any therapeutic application could be foreseen. A possible way of achieving this goal is by using a chemical-pharmacological approach to increase stem cell plasticity. Along this line, we envisioned the possibility of pre-treating BMSCs and ASCs with reversine, a synthetic purine that has been shown to induce adult cells de-differentiation. In the current study we tested reversine effects on both BMSCs and ASCs to increase their differentiation toward osteoblasts, smooth and skeletal muscle cells. Reversine pre-treatment, at very low concentration (50 nM), caused a marked increase in the differentiation yields of both BMSCs and ASCs.

UI MeSH Term Description Entries
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D053687 Adult Stem Cells Tissue-specific stem cells (also known as Somatic Stem Cells) that appear during fetal development and remain in the body throughout life. The key functions of adult stem cells are to maintain and repair the specific tissues where they reside (e.g. skin or blood). Adult Somatic Stem Cells,Somatic Adult Stem Cells,Somatic Stem Cells,Adult Stem Cell,Somatic Stem Cell,Stem Cell, Somatic,Stem Cells, Adult,Stem Cells, Somatic
D059630 Mesenchymal Stem Cells Mesenchymal stem cells, also referred to as multipotent stromal cells or mesenchymal stromal cells are multipotent, non-hematopoietic adult stem cells that are present in multiple tissues, including BONE MARROW; ADIPOSE TISSUE; and WHARTON JELLY. Mesenchymal stem cells can differentiate into mesodermal lineages, such as adipocytic, osteocytic and chondrocytic. Adipose Tissue-Derived Mesenchymal Stem Cell,Adipose Tissue-Derived Mesenchymal Stromal Cell,Adipose-Derived Mesenchymal Stem Cell,Bone Marrow Mesenchymal Stem Cell,Mesenchymal Stromal Cell,Mesenchymal Stromal Cells,Multipotent Bone Marrow Stromal Cell,Multipotent Mesenchymal Stromal Cell,Adipose Tissue-Derived Mesenchymal Stem Cells,Adipose Tissue-Derived Mesenchymal Stromal Cells,Adipose-Derived Mesenchymal Stem Cells,Adipose-Derived Mesenchymal Stromal Cells,Bone Marrow Mesenchymal Stem Cells,Bone Marrow Stromal Cell,Bone Marrow Stromal Cells,Bone Marrow Stromal Cells, Multipotent,Bone Marrow Stromal Stem Cells,Mesenchymal Progenitor Cell,Mesenchymal Progenitor Cells,Mesenchymal Stem Cell,Mesenchymal Stem Cells, Adipose-Derived,Mesenchymal Stromal Cells, Multipotent,Multipotent Bone Marrow Stromal Cells,Multipotent Mesenchymal Stromal Cells,Stem Cells, Mesenchymal,Wharton Jelly Cells,Wharton's Jelly Cells,Adipose Derived Mesenchymal Stem Cell,Adipose Derived Mesenchymal Stem Cells,Adipose Derived Mesenchymal Stromal Cells,Adipose Tissue Derived Mesenchymal Stem Cell,Adipose Tissue Derived Mesenchymal Stem Cells,Adipose Tissue Derived Mesenchymal Stromal Cell,Adipose Tissue Derived Mesenchymal Stromal Cells,Mesenchymal Stem Cells, Adipose Derived,Progenitor Cell, Mesenchymal,Progenitor Cells, Mesenchymal,Stem Cell, Mesenchymal,Stromal Cell, Mesenchymal,Stromal Cells, Mesenchymal,Wharton's Jelly Cell,Whartons Jelly Cells
D039902 Multipotent Stem Cells Specialized stem cells that are committed to give rise to cells that have a particular function; examples are MYOBLASTS; MYELOID PROGENITOR CELLS; and skin stem cells. (Stem Cells: A Primer [Internet]. Bethesda (MD): National Institutes of Health (US); 2000 May [cited 2002 Apr 5]. Available from: http://www.nih.gov/news/stemcell/primer.htm) Stem Cells, Multipotent,Multipotent Stem Cell,Stem Cell, Multipotent

Related Publications

E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
October 2013, Ultrastructural pathology,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
January 2011, Methods in molecular biology (Clifton, N.J.),
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
May 2010, Tissue engineering. Part A,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
August 2020, BMC veterinary research,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
December 2014, Stem cell research & therapy,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
August 2009, PloS one,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
February 2012, Bulletin of experimental biology and medicine,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
February 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
January 2016, International journal of biological sciences,
E Conforti, and E Arrigoni, and M Piccoli, and S Lopa, and L de Girolamo, and A Ibatici, and A Di Matteo, and G Tettamanti, and A T Brini, and L Anastasia
November 2012, Stem cells and development,
Copied contents to your clipboard!